The reverse transcriptase encoded by LINE-1 retrotransposons in the genesis, progression, and therapy of cancer

Frontiers in Chemistry

Volumn 4, Issue FEB, 2016, Pages

  Sciamanna, Ilaria ^a   De Luca, Chiara ^a   Spadafora, Corrado ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b INSTITUTE OF TRANSLATIONAL PHARMACOLOGY   (Italy)

Author keywords

Cancer heterogeneity; Differentiation therapy; Epigenetics; LINE 1 retrotransposons; Reverse transcriptase; Tumorigenesis

Indexed keywords

EID: 84969523755     PISSN: None     EISSN: 22962646     Source Type: Journal    
DOI: 10.3389/fchem.2016.00006     Document Type: Review

References (118)

1. Aalto, A. P., and Pasquinelli, A. E. (2012). Small non-coding RNAs mount a silent revolution in gene expression. Curr. Opin. Cell Biol. 24, 333-340. doi: 10.1016/j.ceb.2012.03.006
2. Aschacher, T., Wolf, B., Enzmann, F., Kienzl, P., Messner, B., Sampl, S., et al. (2016). LINE-1 induces hTERT and ensures telomere maintenance in tumour cell lines. Oncogene 35, 94-104. doi: 10.1038/onc.2015.65
3. Babushok, D. V., and Kazazian, H. H. Jr. (2007). Progress in understanding the biology of the human mutagen LINE-1. Hum. Mutat. 28, 527-539. doi: 10.1002/humu.20486
4. Baltimore, D. (1970). RNA-dependent DNA polymerase in virions of RNA tumor viruses. Nature 226, 1209-1211. doi: 10.1038/2261209a0
5. Beck, C. R., Garcia-Perez, J. L., Badge, R. M., and Moran, J. V. (2011). LINE-1 elements in structural variation and disease. Annu. Rev. Genomics Hum. Genet. 12, 187-215. doi: 10.1146/annurev-genom-082509-141802
6. Bejerano, G., Pheasant, M., Makunin, I., Stephen, S., Kent, W. J., Mattick, J. S., et al. (2004). Ultraconserved elements in the human genome. Science 304, 1321-1325. doi: 10.1126/science.1098119
7. Belancio, V. P., Roy-Engel, A. M., and Deininger, P. L. (2010). All y'all need to know'bout retroelements in cancer. Semin. Cancer Biol. 20, 200-210. doi: 10.1016/j.semcancer.2010.06.001
8. Beraldi, R., Pittoggi, C., Sciamanna, I., Mattei, E., and Spadafora, C. (2006). Expression of LINE-1 retroposons is essential for murine preimplantation development. Mol. Reprod. Dev. 73, 279-287. doi: 10.1002/mrd.20423
9. Böehne, A., Brunet, F., Galiana-Arnoux, D., Schultheis, C., and Volff, J. N. (2008). Transposable elements as drivers of genomic and biological diversity in vertebrates. Chromosome Res. 16, 203-215. doi: 10.1007/s10577-007-1202-6
10. Borchert, G. M., Holton, N. W., Williams, J. D., Hernan, W. L., Bishop, I. P., Dembosky, J. A., et al. (2011). Comprehensive analysis of microRNA genomic loci identifies pervasive repetitive-element origins. Mob. Genet. Elements 1, 8-17. doi: 10.4161/mge.1.1.15766
11. Bourque, G. (2009). Transposable elements in gene regulation and in the evolution of vertebrate genomes. Curr. Opin. Genet. Dev. 19, 607-612. doi: 10.1016/j.gde.2009.10.013
12. Brouha, B., Schustak, J., Badge, R. M., Lutz-Prigge, S., Farley, A. H., Moran, J. V., et al. (2003). Hot L1s account for the bulk of retrotransposition in the human population. Proc. Natl. Acad. Sci. U.S.A. 100, 5280-5285. doi: 10.1073/pnas.0831042100
13. Callinan, P. A., and Batzer, M. A. (2006). Retrotransposable elements and human disease. Genome Dyn. 1, 104-115. doi: 10.1159/000092503
14. Chen, L., Dahlstrom, J. E., Chandra, A., Board, P., and Rangasamy, D. (2012a). Prognostic value of LINE-1 retrotransposon expression and its subcellular localization in breast cancer. Breast Cancer Res. Treat. 136, 129-142. doi: 10.1007/s10549-012-2246-7
15. Chen, L., Dahlstrom, J. E., Lee, S. H., and Rangasamy, D. (2012b). Naturally occurring endo-siRNA silences LINE-1 retrotransposons in human cells through DNA methylation. Epigenetics 7, 758-771. doi: 10.4161/epi.20706
16. Coufal, N. G., Garcia-Perez, J. L., Peng, G. E., Yeo, G. W., Mu, Y., Lovci, M. T., et al. (2009). L1 retrotransposition in human neural progenitor cells. Nature 460, 1127-1131. doi: 10.1038/nature08248
17. Cruz, F. D., and Matushansky, I. (2012). Solid tumor differentiation therapy-is it possible? Oncotarget 3, 559-567. doi: 10.18632/oncotarget.512
18. Dai, L., Huang, Q., and Boeke, J. D. (2011). Effect of reverse transcriptase inhibitors on LINE-1 and Ty1 reverse transcriptase activities and on LINE-1 retrotransposition. BMC Biochem. 2:18. doi: 10.1186/1471-2091-12-18
19. Damm, K., Hemmann, U., Garin-Chesa, P., Hauel, N., Kauffmann, I., Priepke, H., et al. (2001). A highly selective telomerase inhibitor limiting human cancer cell proliferation. EMBO J. 20, 6958-6968. doi: 10.1093/emboj/20.24.6958
20. Dewannieux, M., Esnault, C., and Heidmann, T. (2003). LINE-mediated retrotransposition of marked Alu sequences. Nat. Genet. 35, 41-48. doi: 10.1038/ng1223
21. Djebali, S., Davis, C. A., Merkel, A., Dobin, A., Lassmann, T., Mortazavi, A., et al. (2012). Landscape of transcription in human cells. Nature 489, 101-108. doi: 10.1038/nature11233
22. Doucet, A. J., Droc, G., Siol, O., Audoux, J., and Gilbert, N. (2015). U6 snRNA Pseudogenes: markers of retrotransposition dynamics in mammals. Mol. Biol. Evol. 32, 1815-1832. doi: 10.1093/molbev/msv062
23. Doucet-O'Hare, T. T., Rodic, N., Sharma, R., Darbari, I., Abril, G., Choi, J. A., et al. (2015). LINE-1 expression and retrotransposition in Barrett's esophagus and esophageal carcinoma. Proc. Natl. Acad. Sci. U.S.A. 112, E4894-E900. doi: 10.1073/pnas.1502474112
24. Esnault, C., Maestre, J., and Heidmann, T. (2000). Human LINE retrotransposons generate processed pseudogenes. Nat. Genet. 24, 363-367. doi: 10.1038/74184
25. Esteller, M. (2011). Non-coding RNAs in human disease. Nat. Rev. Genet. 12, 861-874. doi: 10.1038/nrg3074
26. Ewing, A. D., Gacita, A., Wood, L. D., Ma, F., Xing, D., Kim, M. S., et al. (2015). Widespread somatic L1 retrotransposition occurs early during gastrointestinal cancer evolution. Genome Res. 25, 1536-1545. doi: 10.1101/gr.196238.115
27. Fatica, A., and Bozzoni, I. (2014). Long non-coding RNAs: new players in cell differentiation and development. Nat. Rev. 15, 7-21. doi: 10.1038/nrg3606
28. Feschotte, C. (2008). Transposable elements and the evolution of regulatory networks. Nat Rev. Genet. 9, 397-405. doi: 10.1038/nrg2337
29. Garcia-Perez, J. L., Marchetto, M. C. N., Muotri, A. R., Coufal, N. C., Gage, F. H., O'shea, K. S., et al. (2007). LINE-1 retrotransposition in human embryonic stem cells. Hum. Mol. Genet. 16, 1569-1577. doi: 10.1093/hmg/ddm105
30. Gaur, A., Jewell, D. A., Liang, Y., Ridzon, D., Moore, J. H., and Chen, C., et al. (2007). Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res. 67, 2456-2468. doi: 10.1158/0008-5472.CAN-06-2698
31. Giordano, R., Magnano, A. R., Zaccagnini, G., Pittoggi, C., Moscufo, N., Lorenzini, R., et al. (2000). Reverse transcriptase activity in mature spermatozoa of mouse. J. Cell Biol. 148, 1107-1113. doi: 10.1083/jcb.148.6.1107
32. Goodier, J. L., and Kazazian, H. H. Jr. (2008). Retrotransposons revisited: the restraint and rehabilitation of parasites. Cell 135, 23-35. doi: 10.1016/j.cell.2008.09.022
33. Gualtieri, A., Andreola, F., Sciamanna, I., Sinibaldi-Vallebona, P., Serafino, A., and Spadafora, C. (2013). Increased expression and copy number amplification of LINE-1 and SINE B1 retrotransposable elements in murine mammary carcinoma progression. Oncotarget 4, 1882-1893. doi: 10.18632/oncotarget.1188
34. Guy, C. T., Cardiff, R. D., and Muller, W. J. (1992). Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell. Biol. 12, 954-961. doi: 10.1128/MCB.12.3.954
35. Hagan, C. R., and Rudin, C. M. (2002). Mobile genetic element activation and genotoxic cancer therapy potential clinical implications. Am. J. Pharmacogenomics 2, 25-35. doi: 10.2165/00129785-200202010-00003
36. Hanahan, D. (2014). Rethinking the war on cancer. Lancet 383, 558-563. doi: 10.1016/S0140-6736(13)62226-6
37. Hancks, D. C., and Kazazian, H. H. Jr. (2012). Active human retrotransposons: variation and disease. Curr. Opin. Genet. Dev. 22, 191-203. doi: 10.1016/j.gde.2012.02.006
38. Hecht, M., Erber, S., Harrer, T., Klinker, H., Roth, T., Parsch, H., et al. (2015). Efavirenz has the highest anti-proliferative effect of non-nucleoside reverse transcriptase pnhibitors against pancreatic cancer cells. PLoS ONE 10:e0130277. doi: 10.1371/journal.pone.0130277
39. Herschhorn, A., and Hizi, A. (2010). Retroviral reverse transcriptases. Cell. Mol. Life Sci. 67, 2717-2747. doi: 10.1007/s00018-010-0346-2
40. Houédé, N., Pulido, M., Mourey, L., Joly, F., Ferrero, J. M., Bellera, C., et al. (2014). A phase II trial evaluating the efficacy and safety of efavirenz in metastatic castration-resistant prostate cancer. Oncologist 19, 1227-1228. doi: 10.1634/theoncologist.2014-0345
41. International Human Genome Sequencing Consortium (2001). Initial sequencing and analysis of the human genome. Nature 409, 860-921. doi: 10.1038/35057062
42. Iskow, R. C., McCabe, M. T., Mills, R. E., Torene, S., Pittard, W. S., Neuwald, A. F., et al. (2010). Natural mutagenesis of human genomes by endogenous retrotransposons. Cell 141, 1253-1261. doi: 10.1016/j.cell.2010.05.020
43. Jansson, M. D., and Lund, A. H. (2012). MicroRNA and cancer. Mol. Oncol. 6, 590-610. doi: 10.1016/j.molonc.2012.09.006
44. Kaçar, Y., Thomann, H. U., and Gross, H. J. (1992). The first human genes for tRNA(ArgICG), tRNA(GlyUCC), and tRNA(ThrIGU) and more tRNA(Val) pseudogenes: expression and pre-tRNA maturation in HeLa cell-free extracts. DNA Cell Biol. 11, 781-790. doi: 10.1089/dna.1992.11.781
45. Kaer, K., and Speek, M. (2013). Retroelements in human disease. Gene 518, 231-241. doi: 10.1016/j.gene.2013.01.008
46. Kaiser, S., Park, Y. K., Franklin, J. L., Halberg, R. B., Yu, M., Jessen, W. J., et al. (2007). Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol. 8:R131. doi: 10.1186/gb-2007-8-7-r131
47. Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature 502, 333-339. doi: 10.1038/nature12634
48. Kano, H., Godoy, I., Courtney, C., Vetter, M. R., Gerton, G. L., Ostertag, E. M., et al. (2009). L1 retrotransposition occurs mainly in embryogenesis and creates somatic mosaicism. Genes Dev. 23, 1303-1312. doi: 10.1101/gad.1803909
49. Kapusta, A., Kronenberg, Z., Lynch, V. J., Zhuo, X., Ramsay, L. A., Bourque, G., et al. (2013). Transposable elements are major contributors to the origin, diversification, and regulation of vertebrate long noncoding RNAs. PLoS Genet. 9:e1003470. doi: 10.1371/journal.pgen.1003470
50. Kelley, D., and Rinn, J. (2012). Transposable elements reveal a stem cell-specific class of long noncoding RNAs. Genome Biol. 13:R107. doi: 10.1186/gb-2012-13-11-r107
51. Kim, V. N., Han, J., and Siomi, M. C. (2009). Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 10, 126-139. doi: 10.1038/nrm2632
52. Klein, C. A. (2009). Parallel progression of primary tumours and metastases. Nat. Rev. Cancer 9, 302-312. doi: 10.1038/nrc2627
53. Kulpa, D. A., and Moran, J. V. (2006). Cis-preferential LINE-1 reverse transcriptase activity in ribonucleoprotein particles. Nat. Struc. Mol. Biol. 13, 655-660. doi: 10.1038/nsmb1107
54. Landriscina, M., Fabiano, A., Altamura, S., Bagala, C., Piscazzi, A., Cassano, A., et al. (2005). Reverse transcriptase inhibitors downregulate cell proliferation in vitro and in vivo and restore TSH signaling and iodine uptake in human thyroid anaplastic carcinoma. J. Clin. Endocrinol. Metab. 90, 5663-5671. doi: 10.1210/jc.2005-0367
55. Lee, E., Iskow, R., Yang, L., Gokcumen, O., Haseley, P., Luquette, L. J. III., et al. (2012). Landscape of somatic retrotransposition in human cancers. Science 337, 967-971. doi: 10.1126/science.1222077
56. Lehnert, S., Van Loo, P., Thilakarathne, P. J., Marynen, P., Verbeke, G., and Schuit, F. (2009). Evidence for co-evolution between human microRNAs and Alu-repeats. PLoS ONE 4:e4456. doi: 10.1371/journal.pone.0004456
57. Leszczyniecka, M., Roberts, T., Dent, P., Grant, S., and Fisher, P. B. (2001). Differentiation therapy of human cancer: basic science and clinical applications. Pharmacol. Ther. 90, 105-196. doi: 10.1016/S0163-7258(01)00132-2
58. Levin, H. L., and Moran, J. V. (2011). Dynamic interactions between transposable elements and their hosts. Nat. Rev. Genet. 12, 615-627. doi: 10.1038/nrg3030
59. Li, L. C. (2014). Chromatin remodeling by the small RNA machinery in mammalian cells. Epigenetics 9, 1-8. doi: 10.4161/epi.26830
60. Lotem, J., and Sachs, L. (2002). Epigenetics wins over genetics: induction of differentiation in tumor cells. Semin. Cancer Biol. 12, 339-346. doi: 10.1016/S1044-579X(02)00054-8
61. Lowe, C. B., and Haussler, D. (2012). 29 Mammalian genomes reveal novel exaptations of mobile elements for likely regulatory functions in the human genome. PLoS ONE 7:e43128. doi: 10.1371/journal.pone.0043128
62. Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., and Peck, D., et al. (2005). MicroRNA expression profiles classify human cancers. Nature 435, 834-838. doi: 10.1038/nature03702
63. Ma, Y., Zhang P., Wang, F., Yang, J., Yang, Z., and Qin, H. (2010). The relationship between early embryo development and tumourigenesis. J. Cell. Mol. Med. 14, 2697-2701. doi: 10.1111/j.1582-4934.2010.01191.x
64. Malone, C. D., and Hannon, G. J. (2009). Small RNAs as guardians of the genome. Cell 136, 656-668. doi: 10.1016/j.cell.2009.01.045
65. Mangiacasale, R., Pittoggi, C., Sciamanna, I., Careddu, A., Mattei, E., Lorenzini, R., et al. (2003). Exposure of normal and transformed cells to nevirapine, a reverse transcriptase inhibitor, reduces cell growth and promotes differentiation. Oncogene 22, 2750-2761. doi: 10.1038/sj.onc.1206354
66. Meachem, C. E., and Morrison, S. J. (2013). Tumour heterogeneity and cancer cell plasticity. Nature 501, 328-337. doi: 10.1038/nature12624
67. Miki, Y., Nishisho, I., Horii, A., Miyoshi, Y., Utsunomiya, J., Kinzler, K. W., et al. (1992). Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res. 52, 643-645.
68. Miousse, I. R., and Koturbash, I. (2015). The Fine LINE: methylation drawing the cancer landscape. Biomed Res. Int. 2015:131547. doi: 10.1155/2015/131547
69. Morse, B., Rotherg, P. G., South, V. J., Spandorfer, J. M., and Astrin, S. M. (1988). Insertional mutagenesis of the myc locus by a LINE-1 sequence in a hu-man breast carcinoma. Nature 333, 87-90. doi: 10.1038/333087a0
70. Muñoz-López, M., and García-Pérez, J. L. (2010). DNA Transposons: Nature and application in Genomics. Curr. Biol. 11, 115-128. doi: 10.2174/138920210790886871
71. Nagy, R., Sweet, K., and Eng, C. (2004). Highly penetrant hereditary cancer syndromes. Oncogene 23, 6445-6470. doi: 10.1038/sj.onc.1207714
72. Natoli, C., Ramazzotti, V., Nappi, O., Giacomini, P., Palmeri, S., Salvatore, M., et al. (2011). Unknown primary tumors. Biochim. Biophys. Acta 1816, 13-24. doi: 10.1016/j.bbcan.2011.02.002
73. Nelson, A. C., and Wardle, F. C. (2013). Conserved non-coding elements and cis regulation: actions speak louder than words. Development 140, 1385-1395. doi: 10.1242/dev.084459
74. Nishihara, H., Smit, A. F. A., and Okada, N. (2006). Functional noncoding sequences derived from SINEs in the mammalian genome. Genome Res. 16, 864-874. doi: 10.1101/gr.5255506
75. Ohms, S., Lee, S. H., and Rangasamy, D. (2014). LINE-1 retrotransposons and let-7 miRNA: partners in the pathogenesis of cancer? Front Genet. 5:338. doi: 10.3389/fgene.2014.00338
76. Ohms, S., and Rangasamy, D. (2014). Silencing of LINE-1 retrotransposons contributes to variation in small noncoding RNA expression in human cancer cells. Oncotarget 5, 4103-4117. doi: 10.18632/oncotarget.1822
77. Ohno, S. (1972). So much "junk" DNA in our genome. Brookhaven Symp. Biol. 23, 366-370.
78. Oliver, K. R., and Greene, W. K. (2011). Mobile DNA and the TE-Thrust hypothesis: supporting evidence from the primates. Mob. DNA 2:8. doi: 10.1186/1759-8753-2-8
79. Orgel, L. E., and Crick, F. H. (1980). Selfish DNA: the ultimate parasite. Nature 284, 604-607. doi: 10.1038/284604a0
80. Oricchio, E., Beraldi, R., Sciamanna, I., Tolstonog, G. V., Schumann, G. G., and Spadafora, C. (2007). Distinct roles for LINE-1 and Herv-K retroelements in cell proliferation, differentiation and tumor progression. Oncogene 26, 4226-4233. doi: 10.1038/sj.onc.1210214
81. Ostertag, E. M., Goodier, J. L., Zhang, Y., and Kazazain, H. H. Jr. (2003). SVA elements are nonautonomous retrotransposons that cause disease in humans. Am. J. Hum. Genet. 73, 1444-1451. doi: 10.1086/380207
82. Patnala, R., Lee, S. H., Dahlstrom, J. E., Ohms, S., Chen, L., Dheen, S. T., et al. (2013). Inhibition of LINE-1 retrotransposon-encoded reverse transcriptase modulates the expression of cell differentiation genes in breast cancer cells. Breast. Cancer Res. Treat 143, 239-253. doi: 10.1007/s10549-013-2812-7
83. Pelechano, V., and Steinmetz, L. M. (2013). Gene regulation by antisense transcription. Nat Rev. 14, 880-893. doi: 10.1038/nrg3594
84. Perreault, J., Noël, J. F., Brière, F., Cousineau, B., Lucier, J. F., et al. (2005). Retropseudogenes derived from the human Ro/SS-A autoantigen-associated hY RNAs. Nucleic Acids Res. 33, 2032-2041. doi: 10.1093/nar/gki504
85. Piatek, M. J., and Werner, A. (2014). Endogenous siRNAs: regulators of internal affairs. Biochem. Soc. Trans. 42, 1174-1179. doi: 10.1042/BST20140068
86. Pink, R. C., Wicks, K., Caley, D. P., Punch, E. K., Jacobs, L., and Carter, D. R. F. (2011). Pseudogenes: Pseudo-functional or key regulators in health and disease? RNA 17, 792-798. doi: 10.1261/rna.2658311
87. Pittoggi, C., Sciamanna, I., Mattei, E., Beraldi, R., Lobascio, A. M., Mai, A., et al. (2003). Role of endogenous reverse transcriptase in murine early embryo development. Mol. Reprod. Dev. 66, 225-236. doi: 10.1002/mrd.10349
88. Rebollo, R., Romanish, M. T., and Mager, D. L. (2012). Transposable elements: an abundant and natural source of regulatory sequences for host genes. Annu. Rev. Genet. 46, 21-42. doi: 10.1146/annurev-genet-110711-155621
89. Rodic, N., and Burns, K. H. (2013). Long interspersed element-1 (LINE-1): passenger or driver in human neoplasms? PLoS Genet. 9:e1003402. doi: 10.1371/journal.pgen.1003402
90. Rodic, N., Sharma, R., Sharma, R., Zampella, J., Dai, L., Taylor, M. S., et al. (2014). Long Interspersed Element-1 protein expression is a hallmark of many human cancers. Am. J. Pathol. 184, 1280-1286. doi: 10.1016/j.ajpath.2014.01.007
91. Rodic, N., Steranka, J. P., Makohon-Moore, A., Moyer, A., Shen, P., Sharma, R., et al. (2015). Retrotransposon insertions in the clonal evolution of pancreatic ductal adenocarcinoma. Nat. Med. 21, 1060-1064. doi: 10.1038/nm.3919
92. Sciamanna, I., Gualtieri, A., Cossetti, C., Osimo, E. F., Ferracin, M., Macchia, G., et al. (2013). A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines. Oncotarget 4, 2271-2287. doi: 10.18632/oncotarget.1403
93. Sciamanna, I., Gualtieri, A., Piazza, P. V., and Spadafora, C. (2014). Regulatory roles of LINE-1-encoded reverse transcriptase in cancer onset and progression. Oncotarget 5, 8039-8051. doi: 10.18632/oncotarget.2504
94. Sciamanna, I., Landriscina, M., Pittoggi, C., Quirino, M., Marelli, C., Beraldi, R., et al. (2005). Inhibition of endogenous reverse transcriptase antagonizes human tumor growth. Oncogene 24, 3923-3931. doi: 10.1038/sj.onc.1208562
95. Sciamanna, I., Vitullo, P., Curatolo, A., and Spadafora, C. (2011). A reverse transcriptase-dependent mechanism is essential for murine preimplantation development. Genes 2, 360-373. doi: 10.3390/genes2020360
96. Shukla, R., Upton, K. R., Muñoz-Lopez, M., Gerhardt, D. J., Fisher, M. E., Nguyen, T., et al. (2013). Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma. Cell 153, 101-111. doi: 10.1016/j.cell.2013.02.032
97. Sinibaldi-Vallebona, P., Matteucci, C., and Spadafora, C. (2011). Retrotransposon-encoded reverse transcriptase in the genesis, progression and cellular plasticity of human cancer. Cancers 3, 1141-1157. doi: 10.3390/cancers3011141
98. Slotkin, R. K., and Martienssen, R. (2007). Transposable elements and the epigenetic regulation of the genome. Nat. Rev. Genet. 8, 272-285. doi: 10.1038/nrg2072
99. Solyom, S., Ewing, A. D., Rahrmann, E. P., Doucet, T., Nelson, H. H., Burns, M. B., et al. (2012). Extensive somatic L1 retrotransposition in colorectal tumors. Genome Res. 22, 2328-2338. doi: 10.1101/gr.145235.112
100. Sottoriva, A., Kang, H., Ma, Z., Graham, T. A., Salomon, M. P., Zhao, J., et al. (2015). A Big Bang model of human colorectal tumor growth. Nat. Genet. 47, 209-216. doi: 10.1038/ng.3214
101. Spadafora, C. (2008). Sperm-mediated 'reverse' gene transfer: a role of reverse transcriptase in the generation of new genetic information. Hum. Reprod. 23, 735-740. doi: 10.1093/humrep/dem425
102. Spadafora, C. (2015). A LINE-1-encoded reverse transcriptase-dependent regulatory mechanism is active in embryogenesis and tumorigenesis. Ann. N.Y. Acad. Sci. 1341, 164-171. doi: 10.1111/nyas.12637
103. Stella, G. M., Senetta, R., Cassenti, A., Ronco, M., and Cassoni, P. (2012). Cancers of unknown primary origin: current perspectives and future therapeutic strategies. J. Translat. Med. 10:12. doi: 10.1186/1479-5876-10-12
104. Suh, N., Baehner, L., Moltzahn, F., Melton, C., Shenoy, A., Chen, J., et al. (2010). MicroRNA function is globally suppressed in mouse oocytes and early embryos. Curr. Biol. 20, 271-277. doi: 10.1016/j.cub.2009.12.044
105. Tang, X. H., and Gudas, L. J. (2011). Retinoids, retinoic acid receptors, and cancer. Annu. Rev. Pathol. 6, 345-364. doi: 10.1146/annurev-pathol-011110-130303
106. Temin, H. M. (1971). Guest editorial. The protovirus hypothesis: speculations on the significance of RNA-directed DNA synthesis for normal development and for carcinogenesis. J. Natl. Cancer Inst. 46, III-VI.
107. Temin, H. M., and Mizutani, S. (1970). RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature 226, 1211-1213. doi: 10.1038/2261211a0
108. Terasaki, N., Goodier, J. L., Cheung, L. E., Wang, Y. J., Kajikawa, M., Kazazian, H. H. Jr., et al. (2013). In vitro screening for compounds that enhance human L1 mobilization. PLoS ONE 8:e74629. doi: 10.1371/journal.pone.0074629
109. The ENCODE and Project Consortium (2012). An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74. doi: 10.1038/nature11247
110. Ullu, E., and Weiner, A. M. (1984). Human genes and pseudogenes for the 7SL RNA component of signal recognition particle. EMBO J. 3, 3303-3310
111. van den Hurk, J. A. J. M., Meij, I. C., Seleme, M. C., Kano, H., Nikopoulos, K., Hoefsloot, L. H., et al. (2007). L1 retrotransposition can occur early in human embryonic development. Hum. Mol. Genet. 16, 1587-1592. doi: 10.1093/hmg/ddm108
112. Vitullo, P., Sciamanna, I., Baiocchi, M., Sinibaldi-Vallebona, P., and Spadafora, C. (2012). LINE-1 retrotransposon copies are amplified during murine early embryo development. Mol. Reprod. Dev. 79, 118-127. doi: 10.1002/mrd.22003
113. Wallace, M. R., Andersen, L. B., Saulino, A. M., Gregory, P. E., Glover, T. W., and Collins, F. S. (1991). A de novo Alu insertion results in neurofibromatosis type 1. Nature 353, 864-866. doi: 10.1038/353864a0
114. Watanabe, T., Tomizawa, S., Mitsuya, K., Totoki, Y., Yamamoto, Y., et al. (2011). Role for piRNAs and noncoding RNA in de novo DNA methylation of the imprinted mouse Rasgrf1 locus. Science 332, 848-852. doi: 10.1126/science.1203919
115. Wei, W., Gilbert, N., Ooi, S. L., Lawler, J. F., Ostertag, E. M., Kazazian, H. H., et al. (2001). Human L1 retrotransposition: cis preference versus trans complementation. Mol. Cell. Biol. 21, 1429-1439. doi: 10.1128/MCB.21.4.1429-1439.2001
116. Woolfe, A., Goodson, M., Goode, D. K., Snell, P., McEwen, G. K., Vavouri, T., et al. (2005). Highly conserved non-coding sequences are associated with vertebrate development. PLoS Biol. 3:e7. doi: 10.1371/journal.pbio.0030007
117. Yang, N., and Kazazian, H. H. Jr. (2006). L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs in human cultured cells. Nat. Struc. Mol. Biol. 13, 763-771. doi: 10.1038/nsmb1141
118. Zhang, H., Chen, Z., Wang, X., Huang, Z., He, Z., and Chen, Y. (2013). Long non-coding RNA: a new player in cancer. J. Hemat. Oncol. 6:37. doi: 10.1186/1756-8722-6-37